Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans

Neuroscience Letters

Volumn 256, Issue 3, 1998, Pages 135-138

  Eleopra, Roberto ^a   Tugnoli, Valeria ^a   Rossetto, Ornella ^b   De Grandis, Domenico ^c   Montecucco, Cesare ^b  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Ospedale Civile   (Italy)

Author keywords

Botulinum neurotoxin A; Botulinum neurotoxin E; Dystonia; Electrophysiology

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; BOTULISM; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MUSCLE ACTION POTENTIAL; PRIORITY JOURNAL; TOXICITY TESTING; TOXIN ANALYSIS; VOLUNTEER;

ACTION POTENTIALS; ADULT; AGED; BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; DRUG SYNERGISM; DYSTONIA; ELECTRIC STIMULATION; FEMALE; FOOT; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEUROMUSCULAR JUNCTION; TIME FACTORS;

EID: 0032515187     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00775-7     Document Type: Article

References (17)

1. Borodic G., Johnson E., Goodnough M., Schantz E. botulinum toxin therapy, immunologic resistance. Neurology. 46:1996;26-29.
2. Brin M. botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve. 6(Suppl.):1997;S146-S165.
3. Cherington M. Clinical spectrum of Botulism. Muscle Nerve. 21:1998;701-710.
4. Eleopra R., Tugnoli V., Rossetto O., Montecucco C., De Grandis D. botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human. Neurosci. Lett. 224:1997;91-94.
5. Eleopra R., Tugnoli V., De Grandis D., Montecucco C. botulinum toxin serotype C treatment in subjects affected by focal dystonia and resistant to botulinum toxin serotype A. Neurology. 50(Suppl. 4):1998;A72.
6. Greene P.E., Fahn S. Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients. Mov. Disord. 11:1996;181-184.
7. Hamjian J.A., Walker F.O. Serial neurophysiological studies of intramuscular botulinum A toxin in man. Muscle Nerve. 17:1994;1385-1392.
8. Jankovic, J. and Hallett, M. (Eds.), Therapy With Botulinum Toxin, Marcel Dekker, New York, 1994.
9. Jankovic J., Schwartz K. Response and immunoresistance to botulinum toxin injections. Neurology. 45:1995;1743-1746.
10. Kessler K.R., Benecke R. The EBD test: a clinical test for the detection of antibodies to botulinum toxin type A. Mov. Disord. 12:1997;95-99.
11. Lew M.F., Adornato B.T., Duane D.D., Dykstra D.D., Factor S.A., Massey J.M., Brin M.F., Jankovic J., Rodnitzky R.L., Singer C., Swenson M.R., Tarsy D., Murray J.J., Koller M., Wallace J.D. botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology. 49:1997;701-707.
12. Mezaki T., Kaji R., Kohara N., Fujii H., Katayama M., Shimizu T., Kimura J., Brin M.F. Comparison of therapeutic efficacies of type A and F botulinum toxins for blepharospasm: a double-blind, controlled study. Neurology. 45:1995;506-508.
13. Montecucco C., Schiavo G. Structure and function of Tetanus and botulinum neurotoxins. Quart. Rev. Biophys. 28:1995;423-472.
14. Montecucco C., Schiavo G. Tetanus and botulinum neurotoxins: isolation and assay. Methods Enzymol. 248:1995;643-652.
15. Tsui J.K.C., Hayward M., Ming Mak E.K., Schulzer M. botulinum toxin type B in the treatment of cervical dystonia: a pilot study. Neurology. 45:1995;2109-2110.
16. Sloop R.R., Cole B.A., Escutin R.O. Human response to botulinum toxin injection: type B compared with type A. Neurology. 49:1997;189-194.
17. Sloop R.R., Escutin R.O., Matus J.A., Cole B.A., Peterson G.W. Dose-response curve of human extensor digitorum brevis muscle function to i.m. injected botulinum toxin type A. Neurology. 46:1996;1382-1386.